The 6 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +139.52% increase from the last price of 3.34.
The current consensus among 6 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.09
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.